Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-26-052911
Filing Date
2026-08-05
Accepted
2026-08-05 07:05:13
Documents
11
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 6-K form6-k20260630q12027.htm 6-K 17733
2 EX-99.1 fs20260630q12027.htm EX-99.1 698492
3 EX-99.2 mda20260630q12027.htm EX-99.2 402144
4 EX-99.3 a993certificationofceo.htm EX-99.3 4722
5 EX-99.4 a994certificationofcfo.htm EX-99.4 4719
6 a993certificationofceo001.jpg GRAPHIC 212144
7 a993certificationofceo002.jpg GRAPHIC 66070
8 a994certificationofcfo001.jpg GRAPHIC 212332
9 a994certificationofcfo002.jpg GRAPHIC 66356
10 picture11.jpg GRAPHIC 52406
11 picture1b.jpg GRAPHIC 52406
  Complete submission text file 0001628280-26-052911.txt   2040698
Mailing Address 409 GRANVILLE STREET SUITE 1700 VANCOUVER A1 V6C 1T2
Business Address 2207 90B STREET SW EDMONTON A0 T6X 1V8 604-362-5207
AURORA CANNABIS INC (Filer) CIK: 0001683541 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-38691 | Film No.: 261241294
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)